| Dr Wael Al-halaseh, MD | |
|
306 Medical Center Dr Sw, Fort Payne, AL 35968-3416 | |
| (256) 845-9255 | |
| (256) 845-9349 |
| Full Name | Dr Wael Al-halaseh |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 25 Years |
| Location | 306 Medical Center Dr Sw, Fort Payne, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760645311 | NPI | - | NPPES |
| 1760645311 | Medicaid | AL | |
| 510-47874 | Other | AL | AL BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 25MA07880900 (New Jersey) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | MD28946 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Dekalb Regional Medical Center | Fort payne, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fort Payne Clinic Corp | 5698779304 | 21 |
News Archive
Epigenetic therapies - targeting enzymes that alter what genes are turned on or off in a cell - are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.
Scientists have identified a key molecular regulator of cardiac hypertrophy (enlargement of the heart) that may provide a therapeutic target for a major risk factor of heart failure and early death.
ESCO Technologies Inc. (NYSE: ESE) today announced that TekPackaging LLC (Tek) has been awarded a production contract to be the exclusive manufacturer of Thermoscan(R) ear thermometer probe covers for distribution worldwide. Thermoscan is the market leader and healthcare industry standard for electronic thermometers.
Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) that is also in single-agent clinical trials, including a pivotal trial for relapsed and refractory Hodgkin lymphoma and a phase II trial for systemic anaplastic large cell lymphoma.
› Verified 6 days ago
| Entity Name | Fort Payne Clinic Corp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396764395 PECOS PAC ID: 5698779304 Enrollment ID: O20060912000391 |
News Archive
Epigenetic therapies - targeting enzymes that alter what genes are turned on or off in a cell - are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.
Scientists have identified a key molecular regulator of cardiac hypertrophy (enlargement of the heart) that may provide a therapeutic target for a major risk factor of heart failure and early death.
ESCO Technologies Inc. (NYSE: ESE) today announced that TekPackaging LLC (Tek) has been awarded a production contract to be the exclusive manufacturer of Thermoscan(R) ear thermometer probe covers for distribution worldwide. Thermoscan is the market leader and healthcare industry standard for electronic thermometers.
Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) that is also in single-agent clinical trials, including a pivotal trial for relapsed and refractory Hodgkin lymphoma and a phase II trial for systemic anaplastic large cell lymphoma.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Wael Al-halaseh, MD 306 Medical Center Dr Sw, Fort Payne, AL 35968-3416 Ph: (256) 845-9255 | Dr Wael Al-halaseh, MD 306 Medical Center Dr Sw, Fort Payne, AL 35968-3416 Ph: (256) 845-9255 |
News Archive
Epigenetic therapies - targeting enzymes that alter what genes are turned on or off in a cell - are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.
Scientists have identified a key molecular regulator of cardiac hypertrophy (enlargement of the heart) that may provide a therapeutic target for a major risk factor of heart failure and early death.
ESCO Technologies Inc. (NYSE: ESE) today announced that TekPackaging LLC (Tek) has been awarded a production contract to be the exclusive manufacturer of Thermoscan(R) ear thermometer probe covers for distribution worldwide. Thermoscan is the market leader and healthcare industry standard for electronic thermometers.
Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) that is also in single-agent clinical trials, including a pivotal trial for relapsed and refractory Hodgkin lymphoma and a phase II trial for systemic anaplastic large cell lymphoma.
› Verified 6 days ago
Dr. Carmelo Cabalu Mendiola, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2202 Jordan Road Sw, Suite 500, Fort Payne, AL 35968 Phone: 256-844-2825 Fax: 256-844-2834 | |
Dr. Daniel Martin Mince, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 415 Medical Center Dr Sw, Fort Payne, AL 35968 Phone: 256-997-2820 Fax: 256-997-2890 | |
Dr. Thomas Dalsgaard Nielsen, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 415 Medical Center Dr Sw, Fort Payne, AL 35968 Phone: 256-997-2820 | |
Dr. John Bennett Weaver Ii, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1906 Glenn Blvd Sw, Fort Payne, AL 35968 Phone: 256-845-7555 Fax: 256-845-4499 | |
Dr. Luz Jovita Crystal, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2202 Jordan Road Sw, Suite 500, Fort Payne, AL 35968 Phone: 256-844-2825 Fax: 256-844-2834 | |
Dr. Frederico Yambao Fernandez, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2804 Greenhill Blvd Nw, Suite 101, Fort Payne, AL 35968 Phone: 256-845-0023 Fax: 256-845-0238 |